Hologic, Inc. et al v. SenoRx, Inc

Filing 519

AMENDED STIPULATION AND ORDER 517 Extending Case Schedule Deadlines. Signed by Judge Ronald M. Whyte on 8/8/12. (jg, COURT STAFF) (Filed on 8/8/2012)

Download PDF
1 2 3 4 Nicholas H. Lee (SBN 229588) ARNOLD & PORTER LLP 777 S. Figueroa Street, 44th Floor Los Angeles, CA 90017-5844 Telephone: (213) 243-4000 Facsimile: (213) 243-4199 E-mail: nicholas.lee@aporter.com Jeffrey E. Faucette (SBN 193066) SKAGGS FAUCETTE LLP One Embarcadero Center, Suite 500 San Francisco, CA 94111 Telephone: (415) 315-1669 Facsimile: (415) 433-5994 E-mail: jeff@skaggsfaucette.com Matthew M. Wolf (admitted pro hac vice) John E. Nilsson (admitted pro hac vice) ARNOLD & PORTER LLP 555 Twelfth Street N.W. Washington, DC 20004-1206 Telephone: (202) 942-5000 Facsimile: (202) 942-5999 E-mail: matthew.wolf@aporter.com E-mail: john.nilsson@aporter.com Bruce R. Genderson (admitted pro hac vice) Aaron P. Maurer (admitted pro hac vice) Adam D. Harber (admitted pro hac vice) WILLIAMS & CONNOLLY LLP 725 Twelfth Street, NW Washington, DC 20005 Telephone: (202) 434-5000 Facsimile: (202) 434-5029 E-mail: bgenderson@wc.com E-mail: amaurer@wc.com E-mail: aharber@wc.com 5 6 7 8 9 10 11 12 Attorneys for Plaintiffs HOLOGIC, INC., CYTYC CORP. and HOLOGIC L.P. Attorneys for Defendant SENORX, INC. 13 14 IN THE UNITED STATES DISTRICT COURT 15 NORTHERN DISTRICT OF CALIFORNIA 16 SAN JOSE DIVISION 17 18 HOLOGIC, INC., CYTYC CORP. and HOLOGIC L.P., 19 20 21 22 Plaintiffs, Case No.: C-08-0133 RMW AMENDED JOINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES vs. SENORX, INC., Defendant. 23 24 25 26 27 28 AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES CASE NO. C-08-0133 RMW 1 Plaintiffs and Defendant hereby submit this Amended Joint Stipulation and [Proposed] 2 Order requesting an extension of the deadlines in the current Scheduling Order, entered by this 3 Court on March 6, 2012. The parties stipulate and agree to move all deadlines as detailed below. 4 The parties agree that no prejudice will come to this matter by this extension. The parties, through 5 their counsel, hereby lodge the following proposed updated case management statement. 6 I. SCOPE OF ISSUES FOR RETRIAL AND DISCOVERY 7 The only issues remaining for trial are those of invalidity and willfulness. Based upon the 8 January 3, 2012 Case Management Conference, the parties agree to limited discovery as set forth 9 below, and the following updated schedule for such discovery and for the other deadlines in this 10 case. 11 II. PROPOSED SCHEDULE 12 A. Fact Discovery 13 On or before February 28, 2012, Hologic shall identify to SenoRx via letter all objective 14 indicia of non-obviousness on which it intends to rely, with a brief description of the facts on which 15 Hologic will rely to support each alleged indicator. All fact discovery shall be commenced in time 16 to be completed by September 14, 2012. Document production shall be limited to: 17  an updated production of public statements and communications to third-parties 18 concerning the commercial performance, features, clinical performance and/or 19 benefits of any commercial embodiment of an invention(s) of claims 1 and/or 8 of 20 the ‘142 patent. Documents falling within this category would include quarterly and 21 annual reports, press releases, transcripts of investor calls, advertisements, marketing 22 presentations, brochures, sell sheets, and correspondence with customers; 23  alleged to fall within claims 1 and/or 8 of the ‘142 patent; 24 25 annual sales revenue figures for any commercial embodiment of an invention(s)  to the extent that Hologic intends to rely on the Hologic Mammosite® Multi-Lumen 26 product as an embodiment of claims 1 and/or 8 of the ‘142 patent, Hologic shall 27 produce documents concerning the reason(s) a Multi-Lumen product was introduced, 28 the perceived need (or lack thereof) for such a device, the reason(s) the Multi-Lumen -2AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES CASE NO. C-08-0133 RMW 1 product was not introduced earlier, comparisons versus the Single Lumen 2 MammoSite® product, the date of the first proposal for the Multi-Lumen product, 3 the instructions for use for the Multi-Lumen product, and the actual use of the Multi- 4 Lumen product, including any evidence of conformance. 5 Any such production shall be completed by August 14, 2012. In addition, each side may 6 serve one deposition notice pursuant to Rule 30(b)(6) of the Federal Rules of Civil Procedure 7 concerning documents produced pursuant to this order and/or any other discovery provided 8 pursuant to this order. Any such deposition(s) are to be completed on or before September 14, 9 2012. Each party may also update its Rule 26(a) Disclosures pursuant to its obligations under the 10 Federal Rules. 11 B. Expert Discovery 12 All expert discovery shall be commenced in time to be completed by November 20, 2012. 13 Expert discovery shall be limited to the issue of objective evidence of non-obviousness. In this 14 regard, Plaintiff may submit an expert report on the issue of objective evidence of non-obviousness 15 on or before September 18, 2012. Defendant may submit a responsive report on or before October 16 19, 2012. Plaintiff may submit a reply report on or before November 2, 2012. And depositions of 17 experts on the issue of objective evidence of non-obviousness are to be completed on or before 18 November 20, 2012. 19 C. Dispositive Motions 20 Dispositive motions shall be filed no later than December 14, 2012. Responsive briefs shall 21 be filed within 35 days after service of opening briefs. Reply briefs shall be filed within 25 days 22 after service of responsive briefs. Sur-replies shall not be permitted. 23 D. 24 A pre-trial conference shall be set for Thursday, March 14, 2013. Trial shall be set for April 25 Pre-trial and Trial 22, 2013. 26 27 28 -3AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES CASE NO. C-08-0133 RMW Respectfully submitted, 1 2 Dated: July 31, 2012 ARNOLD & PORTER LLP 3 s/ Matthew M. Wolf 4 Matthew M. Wolf 5 7 Attorneys for Plaintiffs HOLOGIC, INC., CYTYC CORP. and HOLOGIC L.P. 8 WILLIAMS & CONNOLLY LLP 9 s/ Bruce R. Genderson 6 10 Bruce R. Genderson 11 Attorneys for Defendant SENORX, INC. 12 13 ATTESTATION UNDER GENERAL ORDER 45 § X.B 14 15 As required by General Order § X.B, I hereby attest that concurrence in the filing of this document was obtained from all signatories to this Amended Joint Case Management Statement. 16 17 /s/ Matthew M. Wolf 18 Matthew M. Wolf Matthew.Wolf@Aporter.com 19 20 ORDER 21 22 23 24 The Court, having considered the parties’ Stipulation Re Case Schedule, hereby grants that proposed schedule. IT IS SO ORDERED Dated: , 2012 ______________________________ Honorable Ronald M. Whyte United States District Judge 25 26 27 28 -4AMENDED J OINT STIPULATION AND [PROPOSED] ORDER EXTENDING CASE SCHEDULE DEADLINES CASE NO. C-08-0133 RMW

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?